Hyperpigmentation Completed Phase 4 Trials for Triclosan (DB08604)

Also known as: Increased pigmentation / Increased skin pigmentation / Skin hyperpigmentation / Hyperpigmentation skin / Hyperpigmentation disorder / (Dyschromia) or (hyperpigmentation) or (pigmentation disorders) / Hyperpigmentation of skin (disorder) / Hyperpigmentation (morphologic abnormality) / Hyperpigmentation disorders / Hypermelanosis

IndicationStatusPhase
DBCOND0034194 (Hyperpigmentation)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01542138Clinical Trial of 4% Niacinamide Versus 0.05% Desonide for the Treatment of Axillar HyperpigmentationTreatment